Description: AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. The monopoly is about to end.
Source: NYTimes.com
Date: Jan 28, 2023
Link: https://www.nytimes.com/2023/01/28/business/humira-abbvie-monopoly.html
Questions for discussion:
- Summarize the issues related to how businesses, governments, insurance companies and consumers are connected to the drug Humira.
- Is this an acceptable system for the industry, in your opinion?
- How might the system be changed in order to be more fair to all parties?
Leave a Reply
You must be logged in to post a comment.